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Abstract
Background: We determined clinical predictors of the rate of rise (RoR) in blood pressure in the morning as well as a novel
measure of the power of the BP surge (BPpower) derived from ambulatory blood pressure recordings.
Methods: BPpower and RoR were calculated from 409 ambulatory blood pressure (ABP) recordings from subjects attending a
cardiovascular risk clinic. Anthropometric data, blood biochemistry, and history were recorded. The 409 subjects were 20–82
years old (average 57, SD = 13), 46% male, 9% with hypertension but not on medication and 34% on antihypertensive
medication.
Results: Average RoR was 11.1 mmHg/hour (SD = 8) and BPpower was 273 mmHg
2/hour (SD = 235). Only cholesterol, low
density lipoprotein and body mass index (BMI) were associated with higher BPpower and RoR (P,0.05) from 25 variables
assessed. BPpower was lower in those taking beta-blockers or diuretics. Multivariate analysis identified that only BMI was
associated with RoR (4.2% increase/unit BMI, P = 0.020) while cholesterol was the only remaining associated variable with
BPpower (17.5% increase/mmol/L cholesterol, P = 0.047). A follow up of 213 subjects with repeated ABP after an average 1.8
years identified that baseline cholesterol was the only predictor for an increasing RoR and BPpower (P,0.05). 37 patients who
commenced statin subsequently had lower BPpower whereas 90 age and weight matched controls had similar BPpower on
follow-up.
Conclusions: Cholesterol is an independent predictor of a greater and more rapid rise in morning BP as well as of further
increases over several years. Reduction of cholesterol with statin therapy is very effective in reducing the morning blood
pressure surge.
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Introduction
The circadian variation in blood pressure (BP) in humans has
been established since the first chronic intra-arterial recordings
were made in the late 1960’s [1]. It is well known that many
factors such as physical activity and periods of rest strongly
influence the diurnal BP pattern as well as circadian variation in
autonomic and hormonal systems. The importance of this
circadian pattern has been brought to the fore by the extensive
literature that has been developed over the last two decades to
show that cardiovascular events, such as stroke, transient ischemic
attacks, myocardial infarction and sudden cardiac death occur
most frequently during the morning hours which coincides with
the rapid rise in BP and heart rate (HR) [2,3,4,5,6,7,8,9]. Stroke is
up to 3 times more likely in the morning [5,10] while the
Framingham study showed that the incidence of sudden death was
nearly twice as likely than at any other time [11]. We have
developed a novel mathematical approach to measure the
morning surge in BP using a logistic equation that contains
separate parameters for the rate of rise (RoR) and the rate of fall as
a parameter for the night plateau and the difference between the
day and night plateau [12]. The model is therefore able to provide
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a non-symmetrical fit of any circadian data and can estimate the
RoR independent of the rate of fall. When applied to data such as
human 24 hour BP and HR recordings, it provides a measure of
the RoR of BP and HR in the morning period which is
independent of what happens at any other time of the day.
In a prospective study of over 300 subjects, we found that there
was a markedly greater RoR in BP and HR in the upper quartile
of daytime ambulatory mean arterial pressure (MAP) [13]. This
finding was not simply because the underlying BP is higher, as we
found no correlation between the RoR in morning systolic BP and
the night time systolic BP [13]. Our study showed that the
duration of the morning surge is similar between the normotensive
and hypertensive participants [13]. Importantly, we have found
that the morning RoR is an independent predictor for myocardial
infarct and stroke. We have extended this approach and developed
a method of assessing the power (effective force) of the morning BP
surge (BPpower) [14]. We found that patients with hypertension and
also those with ‘‘white coat’’ hypertension have markedly
exaggerated morning surge BPpower [14].
Our recent studies suggests that the morning surge is associated
with activation of the sympathetic nervous system [15] and that at
least in young females, dyslipidaemia is associated with sympa-
thetic activation [16]. Hypertensive patients are often found to
have high plasma cholesterol compared to normotensive subjects
[17]. Also epidemiological studies show a positive relationship
between serum cholesterol and BP levels [18,19]. The question is
whether plasma cholesterol or other measures collected as part of
the monitoring of cardiovascular health contribute to the
magnitude of the morning BP surge. In a small preliminary study
that included only 38 normotensive and 42 hypertensive subjects
Martin and colleagues found that there was an association
between fasting LDL cholesterol and morning BP surge as
assessed by 4 different methods including the RoR and BPpower
[20]. These associations were independent of age or waist
circumference [20] but a covariate analysis was not performed
due to the limited numbers. Thus the association between
cholesterol and the morning surge needs to be assessed with a
much larger study in order to account for cofounding factors. The
aim of the current study was to assess the relationship between
plasma cholesterol and the morning BP surge (rate and power) in a
cross sectional and also a 1–2 year follow up study. We also
examined the effect of statin therapy and included other more
established methods of calculating the morning BP surge [21].
Methods
A total of 416 subjects were prospectively recruited from the
Healthy Hearts Clinic of Baker IDI Heart and Diabetes Institute
or from patients attending the Hypertension Diagnostic Service at
the Alfred Hospital Heart Centre (funded and staffed by the Baker
IDI Heart and Diabetes Institute) or Monash Health (Dandenong
Hospital). Seven subjects were excluded as having nocturnal rising
rather than dipping. Of the 409 remainder, 213 were re-examined
in follow up after a median 1.8 years (range 1.1 – 2.2). The
procedures were approved by The Alfred and Monash Health
Human Research Ethics Committee (No: 132/00) and conform to
the ethical principles of the Declaration of Helsinki. All subjects
gave their written informed consent. Participants fasted overnight
and arrived in the morning for clinic assessment of BP, blood
sampling for biochemistry, anthropometrics and questionnaires for
medical history after which an ABP device was fitted to the non-
dominant arm and the patients briefed on the correct use of the
device.
Cardiovascular measurements
ABP was recorded during a typical day using SpaceLabs 90207
or 90217 units (SpaceLabs Medical Inc., Redmond, WA, USA) or
Meditech CardioTens (Meditech Ltd, Budapest, Hungary), which
were set to measure BP every 30 minutes from late morning for
26 hours. The first and last hour of the recordings were not
included in the analysis as they involved fitting and removing the
device in the clinic. Diaries were kept by some patients to record
daily activities including awake and asleep times. Clinic BP was
determined in the reclining position using a mercury sphygmo-
manometer after 5 minute rest and an average of three readings.
Analysis of ambulatory curves
ABP recording data were fitted to a 6 parameter double logistic
equation as described previously [22]. The principle involves the
multiplication of the RoR by the amplitude of the rise which are
calculated from our standard six parameter logistic equation [12].
The method is independent of the recorded waking time as we
have previously shown these to be unreliable in predicting the peak
in BP surge [23]. The novel power function is the first derivative of
the logistic curve multiplied by the amplitude which is the day
night difference between plateaus [14]. In addition, we included
previously used methods of calculating the morning BP surge
(MBPS) which were the night minimum minus the post awake
2 hour period (MBPSNightMin) and the pre awake minus the post
awake 2 hour period (MBPSpre-awake) according to the method of
Kario and colleagues [21]. Our modification was to use mean BP
rather than systolic BP in order to be comparable to the morning
BP power.
Statistical analysis
Data are presented as mean 6 standard deviation (SD) of the
between-patient variation for continuous variables and frequency
(%) for categorical variables. Using the natural log of RoR and
BPpower as outcomes, baseline univariate predictors were deter-
mined using linear regression analysis. The significant univariate
predictors were then used in the multivariate analysis. Similarly,
for predictors of the change in RoR and BPpower as the outcome,
the difference between follow up and baseline were used in both
the uni- and multi-variate analysis. Slopes were considered
significant when P,0.05. Analysis was performed with STATA
version 10 Data Analysis and Statistical Software (StataCorp,
College Station, Texas, USA.).
Results
Subject characteristics
The study group of 409 subjects was made up of 54% female
and 46% male subjects with an average age of 57 years (SD = 13,
range 20–83, median 58, Table 1). Average body mass index
(BMI) was 26.5 kg/m2 with plasma total cholesterol of 5.2 mmol/
L, low density lipoprotein (LDL) 3.4 mm/L, high density
lipoprotein (HDL) 1.4 mmol/L and triglycerides 1.3 mmol/L
(Table 1). While males and females were of similar ages and BMI
plasma cholesterol including HDL and LDL were slightly higher
in females and triglycerides were lower (Table 1, P,0.05 for all).
Males also showed elevated daytime, night time MAP as well a
lesser day night difference than females but there was no difference
between the clinic systolic BP or diastolic BP values (Table 2).
Males and females had similar RoR and BPpower being on average
11 mmHg/h (SD = 8) and 273 mmHg2/h (SD = 235).
Based on clinic BP measurements from the entire group, 14%
would be considered hypertensive (SBP/DBP.140/90) and 33%
were taking antihypertensive therapy with the most common
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therapy being angiotensin converting enzyme inhibitors at 14%.
Based on ABP recordings, 226 (55%) were considered normoten-
sive compared with 183 subjects (45%) with hypertension which
included 137 on antihypertensive therapy and 46 not taking
therapy.
Univariate analysis of rate of morning rise in BP and
power
An initial univariate analysis was performed using the entire 409
recordings. The morning RoR and BPpower were first normalised
by natural log transformation. Total cholesterol and LDL and
BMI but not HDL predicted higher BPpower (P,0.05) and RoR
(P,0.05) (Table 3, Fig. 1 and Fig. 2). By contrast, a lower BPpower
and RoR were predicted by age (Fig 2). BPpower was proportionally
lower in those patients taking beta-blockers or diuretics (Table 3).
We also found there was an association of MBPSNightMin and
MBPSpre-awake with cholesterol (P,0.05), MBPSpre-awake was
associated with LDL cholesterol but neither were associated with
HDL (Fig. 3).
Multivariate analysis of rate of morning rise in BP and
power
Multivariate analysis determined that only BMI predicted
morning RoR (4.2% increase in per unit BMI, P = 0.020), while
total cholesterol was the only remaining predictor for BPpower
(17.5% increase/mmol/L, P = 0.047, Table 3).
Table 1. Clinical characteristics of subject groups.
Subjects Total Females Males P1 Baseline Follow up P2
Number 409 222 187 213 213
Age (years) 56.8612.8 56.6612.7 57.1612.9 0.7 58612.7 59.9612.6 0.2
Weight 77.7614.6 72.9615 83612.1 ,0.001 77.9614.5 78.3615.2 0.8
BMI 26.563.9 26.464.4 26.763.3 0.546 26.964 27.164.1 0.6
Cholesterol (mmol/L) 5.260.9 5.460.9 5.160.9 0.004 5.2860.82 5.0360.89 0.013
LDL (mmol/L) 3.460.9 3.560.9 3.260.9 0.041 3.360.8 3.0160.8 0.004
HDL (mmol/L) 1.460.4 1.560.4 1.260.3 ,0.001 1.560.4 1.460.5 0.9
Triglycerides (mmol/L) 1.360.7 1.260.6 1.560.9 ,0.001 1.460.8 1.461 1.0
Fasting glucose (mmol/L) 5.461.4 5.261.3 5.661.4 0.017 5.661.6 5.361.5 0.2
Clinic BP.140/90 mmHg (%) 14.4 13.5 15.5 0.7 12.5 15.8 0.5
Antihypertensive medication (%) 33.5 33.3 33.7 1.0 33.0 45.2 0.2
ACE Inhibitors (%) 13.9 13.1 15.0 0.7 13.0 18.7 0.3
ARB (%) 11.7 10.4 13.4 0.5 14.0 18.1 0.5
Beta blockers (%) 9.3 7.2 11.8 0.3 8.0 12.7 0.3
Calcium channel blockers (%) 10.0 9.5 10.7 0.8 11.5 18.7 0.2
Diuretics (%) 10.3 9.0 11.8 0.5 9.5 15.1 0.3
Statins (%) 18.1 17.6 18.7 0.8 15.5 24.1 0.2
Values are Mean +/- SD, P1 is the probability for the comparison between females and males. P2 is the probability between baseline and follow up.
doi:10.1371/journal.pone.0093186.t001
Table 2. Clinic blood pressures, day and night MAP, day–night difference, morning rate of rise in MAP, and peak morning MAP
surge power in subject groups.
Subjects Total Females Males P1 Baseline Follow up P2
Recordings 409 222 187 213 213
Clinic SBP (mmHg) 137619 138621 136617 0.4 143621 142619 0.6
Clinic DBP (mm Hg) 83.8610.6 83611 84.869.9 0.1 84.9610.8 84.2610.9 0.6
Clinic BP.140/90 mmHg (%) 14.4 13.5 15.5 12.5 15.8
Daytime MAP (mm Hg) 98.268.7 97.269.6 99.567.4 0.007 98.468.5 9869.2 0.7
Night MAP (mm Hg) 92.868.3 91.469.1 94.466.9 ,0.001 93.268.2 93.168.4 0.9
Day-Night difference (mm Hg) 12.966.7 13.566.7 12.266.5 0.043 12.666.7 12.166.8 0.4
Morning rate of MAP increase (mm Hg/h) 11.168.2 11.468.2 10.768.2 0.4 10.268.6 9.067.6 0.1
Peak morning surge power (mm Hg2/h) 2736235 2896237 2546231 0.1 2486239 2186222 0.2
Values are Mean +/- SD, P1 is the probability for the comparison between females and males. P2 is the probability between baseline and follow up.
doi:10.1371/journal.pone.0093186.t002
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Predicting change in analysis of rate of morning rise in BP
and power
A total of 213 subjects from the main study underwent follow up
ABP monitoring (median follow-up time of 1.8 years) from whom
we calculated the predictors of a change in RoR and BPpower
between baseline and analyzed this by univariate and multivariate
covariance. The univariate analysis indicated that baseline total
cholesterol, LDL, triglycerides, fasting glucose and diabetic
medication were predictors of increases in RoR and BPpower
(Table 4, P,0.05). However, multivariate analysis showed after
adjustment for baseline level of RoR and BPpower as well as time
between visits, that only baseline total cholesterol was a predictor
for increasing RoR and BPpower (P,0.05, Table 4). No association
was found with 24 hour MAP or statin use in any of the analyses.
Effect of starting statin therapy
Statin therapy was commenced between the initial and
subsequent ABP assessments in 37 subjects (Table S1). BPpower
was reduced by 46% but not the day night difference (215%) or
Figure 1. Correlations between natural log morning rate of rise (RoR) in mean arterial pressure (MAP) (left panels) and power (right
panels) and plasma levels of cholesterol (top), low density lipoprotein (LDL, middle) and high density lipoprotein (HDL) from
subjects (n = 409). Thick line represents least squares regression lines and thin lines are 99% confidence limits. r is the correlation co-efficient and P
is the probability.
doi:10.1371/journal.pone.0093186.g001
Figure 2. Correlations between natural log morning rate of rise (RoR) in mean arterial pressure (MAP) (left panels) and power (right
panels) and body mass index (BMI) and age from subjects (n = 409). Thick line represents least squares regression lines and thin lines are
99% confidence limits. r is the correlation co-efficient and P is the probability.
doi:10.1371/journal.pone.0093186.g002
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the morning RoR (226%). Also the MBPS was not affected by the
commencement of statin therapy. The only other change was an
increase in the use of angiotensin receptor blockers but we have
previously shown that the use of these agents does not affect
morning BPpower. Stain therapy reduced plasma cholesterol by
1.2 mmol/L due to a reduction in LDL but not HDL. Plasma
triglycerides were also reduced by 35%.
No difference in any parameter was observed in an aged, weight
and BMI matched control group (n = 100) that had not started
statin therapy by the follow up study. The baseline characteristics
were identical for anthropomorphic, plasma lipids and antihyper-
tensive treatment except that triglycerides were lower.
Discussion
The current study determined independent predictors of the
morning surge in BP using a novel method of analysis of the RoR
as well as an index of the ‘‘power’’ of the BP surge derived from
the product of the rate and amplitude [12,13]. We examined over
20 clinical anthropomorphic, biochemical and treatment indices to
find that the only independent predictor of the morning BPpower
was plasma cholesterol and the best predictor of morning RoR was
BMI. Importantly, we also found that plasma cholesterol at
baseline was the only independent predictor of an increase in the
RoR and an increase in the morning BPpower over the 1–2 year
follow up examination. The latter analysis was adjusted for
Table 3. Linear regression coefficient (b), 95% CI and p-value of baseline predictors of the RoR and BPPower as natural log (ln) from
a univariate and multivariate analysis of 409 subjects.
Univariate ln RoR ln BPPower
Baseline Predictor b 95%CI P-value b 95%CI P-value
Age (yrs) 20.01 20.02,20.001 0.018 20.01 20.02,20.005 0.001
BMI (kg/m2) 0.04 0.004,0.07 0.030 0.03 20.005,0.07 0.087
Male (%) 20.06 20.25,0.12 0.488 20.11 20.32,0.09 0.282
Clinical systolic HPT (%) 20.01 20.21,0.19 0.921 0.06 20.17,0.29 0.603
Clinical diastolic HPT (%) 20.12 20.35,0.11 0.307 20.13 20.40,0.13 0.319
BP .140/90 mmHg (%) 20.10 20.36,0.16 0.432 20.10 20.40,0.19 0.494
Baseline hypertension (%) 20.10 20.29,0.09 0.299 20.09 20.31,0.13 0.418
Cholesterol (mmol/L) 0.11 0.003,0.22 0.043 0.16 0.04,0.28 0.009
LDL (mmol/L) 0.15 0.03,0.27 0.018 0.20 0.07,0.34 0.004
HDL (mmol/L) 0.09 20.20,0.37 0.552 0.14 20.18,0.46 0.402
Triglycerides (mmol/L) 20.04 20.17,0.09 0.531 20.03 20.18,0.12 0.675
Fasting glucose (mmol/L) 20.02 20.09,0.05 0.599 20.04 20.12,0.05 0.389
Current Smokers (%) 0.09 20.38,0.56 0.711 0.04 20.49,0.58 0.882
Family history of CHD (%) 0.16 20.07,0.40 0.177 0.25 20.02,0.51 0.067
Diabetic (%) 20.15 20.59,0.30 0.515 20.13 20.63,0.37 0.610
Any alcohol (%) 0.05 20.05,0.15 0.304 0.07 20.04,0.18 0.219
Antihypertensive medication (%) 20.14 20.33,0.05 0.144 20.13 20.34,0.09 0.247
ACE Inhibitors (%) 20.04 20.29,0.22 0.761 20.04 20.33,0.25 0.772
ARB (%) 20.12 20.40,0.15 0.378 20.01 20.33.0.30 0.938
Beta blockers (%) 20.30 20.62,0.01 0.060 20.49 20.85,20.14 0.007
Calcium channel blocker (%) 20.18 20.48,0.11 0.221 20.23 20.56,0.11 0.186
Diuretics (%) 20.25 20.54,0.04 0.094 20.37 20.70,20.04 0.029
Statins (%) 20.02 20.25,0.22 0.888 20.06 20.33,0.20 0.635
Diabetic medication (%) 20.03 20.64,0.60 0.948 20.10 20.80,0.61 0.789
Multivariate Ln RoR Ln BPPower
Baseline Predictor b 95%CI p-value b 95%CI p-value
Age (yrs) 20.01 20.2,0.006 0.405 20.01 20.02,0.002 0.113
BMI (kg/m2) 0.04 0.01,0.08 0.020 - - -
Cholesterol (mmol/L) 0.07 20.09,0.23 0.379 0.16 0.003,0.32 0.047
Beta Blocker - - - 20.23 20.71,0.24 0.336
Diuretic - - - 20.23 20.71,0.24 0.337
doi:10.1371/journal.pone.0093186.t003
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baseline levels of BPpower which eliminates the cross-sectional
association between cholesterol and morning power from the
follow up study. We also found that commencing statin therapy
markedly reduced the BPpower while no change was observed in
those that did not commence a statin between visits. These
findings suggest that plasma cholesterol may be intimately linked
with the underlying pathological process that is leading to a greater
morning BP surge rather than a simple association.
The mechanism involved in the increase in BP and HR in the
morning period involves activation of a number of systems
associated with arousal as well as circadian rhythms associated
with transitioning from dark to light. The transition from sleep to
awake is associated with activation of the sympathetic nervous
system and increasing levels of plasma catecholamines leading to
greater sympathetic vasoconstrictor tone [24]. Also during the
morning period compared with evening, sympathetic baroreflex
gain is reduced [25], plasma cortisol is elevated [26] and
endothelium dependent forearm vasodilatation is reduced [26].
By contrast there is little circadian rhythm in plasma cholesterol
[26] suggesting that the link between cholesterol and the morning
BPpower in both the cross sectional and longitudinal study is not
simply a co-incidence of an association of circadian rhythms.
Furthermore, we also observed significant correlations with
previous methods of determining the morning BP surge and
cholesterol and LDL cholesterol. These methods developed by
Kario and colleagues encapsulate the change in BP pre and post
waking or post awake minus night minimum. The latter essentially
indicates the magnitude of the morning rise [21,27,28].
Activation of the sympathetic vasomotor drive associated with
arousal in the morning period is a particularly important
mechanism influencing the rise in BP. We have recently found
that there was a close association between an acute increase in
muscle sympathetic activation due to a cold pressor test and the
morning BPpower [15]. Thus it would appear that there is a major
contribution of the morning surge in BP and hence BPpower from
the sympathetic nervous system. We have recently published that
dyslipidaemia (high cholesterol) in young females is associated with
high levels of sympathetic activity compared to normal as
measured by micro-neurography [16]. This association was
independent of age, height, weight or BMI. Furthermore Ekstedt
and colleagues found that total cholesterol, LDL and cortisol but
not HDL, triglycerides or insulin were associated with the
frequency of micro-arousals during sleep [29]. This suggests that
inappropriate activation of the sympathetic nervous system during
sleep (micro-arousals) and at the end of sleep (morning power) can
be predicted by elevated cholesterol.
Plasma cholesterol has long been associated with elevated BP
particularly from major epidemiological studies [17,18,19]. Recent
reports using the hypercholesterolemic LDL receptor knockout
mouse suggest that a possible mechanism may involve cerebral
oxidative stress [30,31,32]. These mice have lower mitochondrial
oxidative capacity due to greater consumption of NADPH-linked
substrates [31] and display greater sympathetic vasomotor drive
[30]. We suggest that this mechanism may underlie the association
between the morning BPpower and cholesterol via a greater
sympathetic contribution to the morning arousal surge in BP. In
support, studies have previously shown an association between
oxidative stress and sympathetic contributions to obesity induced
hypertension [33], renovascular hypertension [34,35], salt sensitive
hypertension [36], a mouse model of neurogenic hypertension
[37]. Conversely inhibiting oxidative stress leads to sympatho-
inhibition [38]. An additional mechanism may involve the known
effect of LDL cholesterol to increase the expression of angiotensin
type 1 receptors in the vasculature [39,40] and promote the
development of hypertension [41]. Activation of the renin-
angiotensin system by hypercholesterolemia may further activate
the sympathetic nervous system through a variety of mechanisms
[42].
Figure 3. Correlations between post awake 2 hours minus night minimum 2 hours in mean arterial pressure (MAP) (left panels) and
post awake 2 hours minus pre awake 2 hours (right panels) and plasma levels of cholesterol (top), low density lipoprotein (LDL,
middle) and high density lipoprotein (HDL) from subjects (n = 307). Thick line represents least squares regression lines and thin lines are 99%
confidence limits. r is the correlation co-efficient and P is the probability.
doi:10.1371/journal.pone.0093186.g003
Table 4. Linear regression coefficient (b), 95% CI and p-value of baseline predictors of the change in natural log (ln) RoR and
BPpower between first follow-up and baseline visits from a univariate and multivariate ANCOVA analysis of recordings from 213
subjects.
ANCOVA - Univariate D ln RoR# D ln BPPower‘
Baseline Predictor b 95%CI P-value b 95%CI P-value
Cholesterol (mmol/L) 0.21 0.05,0.37 0.009 0.29 0.11,0.48 0.002
LDL (mmol/L) 0.24 0.05,0.44 0.015 0.32 0.09,0.56 0.008
Triglycerides (mmol/L) 0.23 0.05,0.42 0.012 0.31 0.10,0.52 0.004
Fasting glucose (mmol/L) -0.11 -0.20,-0.01 0.024 -0.12 -0.23,-0.02 0.025
Diabetic medication -0.95 -1.71,-0.18 0.015 -1.49 -2.38,-0.60 0.001
ANCOVA -Multivariate D ln RoR# D ln BPPower‘
Baseline Predictor b 95%CI P-value b 95%CI P-value
Cholesterol (mmol/L) 0.21 0.05,0.37 0.012 0.29 0.11,0.48 0.002
Fasting glucose (mmol/L) -0.08 -0.18,0.01 0.091 -0.09 -0.20,0.02 0.108
#Also adjusted for baseline ln ROR and time between visits,
‘Also adjusted for baseline ln BPpower and time between visits.
doi:10.1371/journal.pone.0093186.t004
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The strength of our study is that the analysis has used a large
data set with follow up assessments allowing for within subject
analysis which complements the cross sectional analysis. The
multivariate analysis model has allowed us to account for
significant factors such as types of treatment. Interestingly, beta
blockers and diuretics were negatively correlated to morning
BPpower but none of these treatments were independent of
cholesterol. We had previously found that patients taking diuretics
had reduced BPpower [14] and those taking beta blockers trended
similarly but did not reach statistical significance [14]. We did not
observe in the cross sectional study an association between statin
treatment and morning power since only those patients with high
cholesterol levels would be given statins. When we compared the
same subjects before and after commencing statin therapy, a clear
reduction in morning BPpower was observed. The reduction cannot
be explained by any other recorded parameter and was not
observed in an age, weight and BMI matched group that did not
begin statin therapy over a similar time frame.
In conclusion, we used a new measure of the morning BP surge
which incorporates the RoR in BP multiplied by the amplitude,
namely BPpower to show that in a large well characterized group of
subjects that plasma cholesterol was the sole independent
correlate. Importantly cholesterol was the sole predictor of a long
term increase in morning BPpower after adjustment for baseline
BPpower. We suggest that the mechanism may relate to increased
cerebral oxidative stress or activation of the renin-angiotensin
system leading to an activation of the sympathetic nervous system.
Importantly, we found from a limited number of subjects who had
commenced statin therapy that reducing cholesterol had a marked
effect in reducing BPpower. These studies suggest an important link
between two major risk factors in cardiovascular disease, namely
hypertension and dyslipidaemia and offer new insights into their
interaction within the central nervous system. BPpower may
therefore be a useful measure to highlight those subjects at
greatest risk of cardiovascular events and for determining the most
benefit of antihypertensive and cholesterol lowering therapy.
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Table S1 Characteristics and morning surge parame-
ters of 37 subjects before (baseline) and after commenc-
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matched subjects before (baseline) and remaining
without statin treatment on follow up. Values are Mean
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